Blood Test Tracks Early Response to Breast Cancer Drug Eribulin in Landmark Trial
The phase II DETECT IVb trial confirms eribulin's efficacy and safety in HER2-negative metastatic breast cancer and shows that early ...
The phase II DETECT IVb trial confirms eribulin's efficacy and safety in HER2-negative metastatic breast cancer and shows that early ...
New research shows that circulating tumor cells shed migrasomes carrying tumor antigens that activate CD8-positive T cells through cross-presentation, restricting ...
A new review in the Journal of Translational Medicine synthesizes a decade of evidence showing that liquid biopsy analytes such ...
A new Molecular Cancer study reveals how UQCRC2 lactylation and SIRT1-driven mitophagy allow colorectal cancer cells to survive chemotherapy in ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine